IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 221 - 232 of 1433 stories.
February 9, 2015
Dishman Group (Ahmedabad, India), a leading outsourcing partner for the global pharmaceutical industry, announced today FDA has successfully completed inspecting its Veenendaal...
February 6, 2015
Cambrex (East Rutherford, NJ) today announced that it has initiated the second significant expansion of its Charles City, IA, facility in less than three years. The previous expansion...
February 6, 2015
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) reports a 1.7% rise in sales in the fourth quarter of 2014 compared with...
February 6, 2015
Cambrex (East Rutherford, NJ) says its net profits for the fourth quarter of 2014 more than tripled compared with the fourth quarter of 2013, to $27.8 million. Net sales for the fourth...
February 5, 2015
Contract manufacturing organizations (CMOs), including many fine chemical makers, are among the big beneficiaries from changes at big pharmaceutical companies, say attendees at...
February 5, 2015
Pfizer and Hospira (Lake Forest, IL) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading...
February 4, 2015
Regulatory issues, most prominently reform of the Toxic Substances Control Act (TSCA) and trade barriers, have been key topics of discussion at Informex 2015, held this week in New...
February 3, 2015
Galmed and Perrigo sign API manufacturing deal Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver...
February 2, 2015
Amyris (Emeryville, CA) says it plans to offer its synthetic biology discovery and production platform to pharmaceutical makers. Amyris says it will offer an integrated discovery and...
February 1, 2015
The FTC on Friday cleared Sun Pharmaceutical’s $4 billion proposed acquisition of Ranbaxy Laboratories on condition that the companies divest Ranbaxy’s interests in generic...
January 29, 2015
Ash Stevens (Riverview, MI), a provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, says that FDA...
January 29, 2015
Galmed Pharmaceuticals (Tel Aviv), a company focused on developing and commercializing a once-daily, oral medication to treat liver diseases and cholesterol gallstones, says that it...
Pages: « Previous  14 15 16 17 18 19 20 21 22 [23] 24 25 26 27 28 29 30 31 32 Next »




RSS Follow us on Twitter Join us on LinkedIn Like us on Facebook Youtube channel
contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa